Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled trial of atacicept monotherapy in relapsing multiple sclerosis
2007-003936-50Phase 2Completed
- Sponsor
- Merck Serono
- Start
- Jan 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atacicept in multiple sclerosis (MS) (4 arms), sponsored by Merck Serono. Started Jan 2008; status: completed.
02
Drugs
atacicept
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2007-003936-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003936-50.